pocketful logo
Venus Remedies Ltd logo

Venus Remedies Ltd

NSE: VENUSREM BSE: 526953

₹861.70

(9.99%)

Sat, 21 Mar 2026, 07:22 am

mtf coin illustrationMTF 5x

Venus Remedies Enterprise Value (EV)

D/EEVEV/EBITDAP/BP/CFP/EP/SROE %
Particulars20052006200720082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio17.8313.838.502.865.513.993.214.734.5229.5659.8014.230005.498.828.1515.318.84
Price to book ratio9.046.373.680.911.270.780.520.670.610.330.230.310.220.120.090.850.820.470.890.71
Price to sales ratio3.402.471.410.470.690.510.370.590.540.330.240.310.220.130.080.630.600.390.740.62
Price to cash flow ratio32.8614.6015.946.626.884.933.645.195.504.678.084.564.181.760.422.708.615.6410.554.40
Enterprise value3.08B4.33B3.98B2.56B3.65B3.68B3.68B5.36B5.75B4.7B4.3B4.29B3.84B3.36B2.46B3.61B3.52B1.85B3.9B2.38B
Enterprise value to EBITDA ratio14.1413.017.534.014.924.083.614.494.325.305.529.149.7317.616.847.835.713.107.523.61
Debt to equity ratio0.681.541.080.950.870.790.720.720.630.700.770.800.850.900.680.130.100.090.080
Return on equity %66.5358.2949.6938.6225.5422.6517.3016.7015.301.120.38-4.13-8.18-8.23-3.0517.079.695.906.018.64

Venus Remedies Ltd Enterprise Value

The Venus Remedies Ltd Enterprise Value is a key financial metric used by investors to evaluate Venus Remedies Ltd's valuation, profitability, and overall financial performance. Tracking the Venus Remedies Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is currently trading at ₹861.70, with a market capitalization of ₹10.49B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Venus Remedies Ltd Enterprise Value is essential for fundamental analysis.

Venus Remedies Ltd Enterprise Value Current Value

The current Venus Remedies Ltd Enterprise Value stands at 2.38B.

The Venus Remedies Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Venus Remedies Ltd Enterprise Value Historical Trend

The Venus Remedies Ltd Enterprise Value has shown the following historical trend:

  • 2024: 2.38B
  • 2023: 3.9B
  • 2022: 1.85B
  • 2021: 3.52B
  • 2020: 3.61B

The decline in Venus Remedies Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Venus Remedies Ltd Enterprise Value Indicates for Investors

The Venus Remedies Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Venus Remedies Ltd.

Venus Remedies Ltd Enterprise Value Analysis Summary

The Venus Remedies Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Venus Remedies Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Venus Remedies Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800